Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not quite dead as Vystar was granted a summary judgement today in the lawsuit against EMA. EMA’s request for a summary judgement against Vystar was denied
I am having a hard time understanding why this is not great news for current and future Vystar shareholders. If you are a current Vystar shareholder and have 1M shares you can sell today at $20,000. If you hold until January 5, you get and additional $60,000 of Rx Air stock making the effective price of Vystar today at 8 cents. Think selling will dry up. On the other hand the only way to acquire RxAir shares is to buy Vystar shares over the next few months. Buying will go up and a supply demand imbalance will occur.
Vystar is also giving 80% of the RxAir shares to Vystar shareholders while retaining 20%. This allows for the dividend to be tax free and any taxes on subsequent sales are pushed to 2023 which is neat.
The $2.00 per share opening price is a given as that is the price of the last Private tranche according to the press release and the share base is only 35-36M and not 1.2B
Should be an interesting few months to see if the supply demand imbalance develops.
As an academic, my understanding of scientific conferences is to further science and not to influence the price of a stock.
Actually I have been an investor in Vystar for about 20 years which makes my point about patience. It was a private equity investment in a concept brought forward by Travis Honeycutt whom I knew quite well from a fabulous investment in his first company which returned 50:1 when it went public in the 1990’s
My original investment in Vystar was at $2 per share but like many of you was able to take advantage of the gift given to all of us long term investors by the toxic lenders who drove the share price down to 0.0005. Acquiring tens of millions of shares at low prices moved our basis down to less then 0.01.
PATIENCE
Easy list. None
I agree that Vystar has participated in the ILC in the past but tough to spin that as a negative. In fact this is their first plenary session presentation and their first presentation with their partner, CMC. For the first time they have a partner who is the largest distributor of latex in the world and who is committed to advancing the unique properties of Vytex compared to other forms of latex. Will this take time??? Of course!!!! Time means little unless you are a trader
I personally do not believe in the public markets and my public stocks are usually as a result of a long term private equity investment followed by an acquisition or an IPO. Private Equity positions are not subject to this noise one sees daily on sites like IHUB
The noise is usually wrong and always meaningless
I agree that Vystar has participated in the ILC in the past but tough to spin that as a negative. In fact this is their first plenary session presentation and their first presentation with their partner, CMC. For the first time they have a partner who is the largest distributor of latex in the world and who is committed to advancing the unique properties of Vytex compared to other forms of latex. Will this take time??? Of course!!!! Time means little unless you are a trader
I personally do not believe in the public markets and my public stocks are usually as a result of a long term private equity investment followed by an acquisition or an IPO. Private Equity positions are not subject to this noise one sees daily on sites like IHUB
The noise is usually wrong and always meaningless
I expect serious cutting edge scientific data regarding Vytex research into various utilizations. No one can deny the scientific credentials of Dr M and his leading role in the latex research universe. Should be an interesting presentation to a large audience and hopefully will lead to further adoption of Vytex. In this regard, CMC is the perfect partner to advance worldwide sales of Vytex.
I think this focus on tires makes sense as the dry rubber market is larger compared to liquid latex. It is also interesting that Vytex’s advantage is not related to its low protein content and that effect on allergies but that process also reveals other attributes of Vytex
With respect to the RxAir line of products, it is important to understand that these are not one time sales. As schools and offices move to a full reopening they will do everything to make the environment as safe as possible and for every 100,000 Rx400’s sold, you generate $15,000,000 in yearly reoccurring revenue from cartridge replacement. The new shelves also allows the units to be secured.
Sorry. Gave you an incorrect Twitter account for Vystar R&D
It is vytxrnd
For those of you interested in new info on Vystar, it’s R& D group is now posting regularly on Twitter. The Twitter address is vystrnd
The first tweet says that Vystar has been selected to present in the plenary session of the International Latex Conf this summer
You are correct in that Vystar does not have a stellar track record for filing on time yet they do file and they remain in compliance
To do so again, the 10K needs to be out today. Hopefully it will be but I am not expecting much as Rotman’s was closed for 3-4 months by the State in 2020 which must have reduced revenues by 6-8M from the Store alone. I don’t believe the store reopened until June
Whatever the 2020 revenue number, I believe that full year revenue will be exceeded by first quarter revenue alone and the first quarter is due out in less then 30 days and the next 30 days according to Made Millions should be exciting.
Remember RxAir has high quality products are all are FDA cleared. Schools are doing everything possible to reopen safely and offices will also reopen. The States have huge amounts of money to make this happen
The CMC deal re VYTEX is real and will produce revenue.
Bedding made from VYTEX is very comfortable and high quality
FEC is a Diamond in the rough
Made Millions says to be patient so I am being patient. What is another 30-60 days after 10 years believing in Vystar
Vystar shareholders gave up nothing. CMC paying Vystar a royalty per metric ton. They also agreed to defend on the Vytex IP
Think you are very correct about EMA litigation. A smart move would be to attempt to settle quickly because of the domino effect if they are found to be an unregistered broker dealer. The damages will be potentially huge
I just had an opportunity to read the courts decision of EMA vs Vystar handed down on 3/29/21. It denied EMA’s motion for a summary judgement on all claims except that it dismissed Vystar’s claim that EMA acted as an unregistered broker dealer. It allowed Vystar’s defenses that the contract was unconscionable and that EMA manipulated the market to the detriment of Vystar’s share price and the counterclaims associated to go forward and also is allowing Vystar to proceed with full discovery of EMA
I, like you, believe all angles are being explored. It just takes time but this company was essentially bankrupt in October of 2017 prior to the involvement of Steve Rotman. There is no question that there has been progress and your info about the two factories that CMC is dedicating to Vytex is an example of that progress. Most important however is the transition from a raw material company to a company oriented to products
There have been no toxic loans for over two years now and no raising of funds since August of 2020 except for loans by the CEO at very favorable terms. Rotman’s is being transformed and Rx Air has products for both now and the future. COVID is not going away any more then 9/11 went away. It will just create a new normal
Finally, for what it is worth, the conversation board on Yahoo Finance is reporting that EMA’s summary judgement was again denied and Vystar’s request to move forward with discovery secondary to its counter suit has been approved. If true, that should lead to a settlement where hopefully EMA will have to return the tens of millions of Vystar shares it acquired and again hopefully through open market purchases. This has been dragging on for years but it is important and is Vystar’s last piece of litigation.
Google Alert
Digital Journal
Industry Experts predict Vytex to become the world standard for latex
I spent some time yesterday reviewing Vystar’s past financials reported to the SEC. Revenue for 2019 was about 13M ( year Rotmans was acquired ). This year the store was closed for a significant period of time in the second quarter so guessing that 10K will show revenue of about 20M for 2020. The 10K is due on March 31.
Looking at recent tweets and 8K’s, the first quarter of 2021 should exceed yearly revenue of both 2019 and 2020 and may be 3-4X Vystar’s best recorded quarter. Little info to date on Rx 400 sales but Rotmans on a run rate of 15M for the quarter
8K filed earlier today following a press release about a significant addition to the Vystar BOD. Someone who has been a Vystar investor for over ten years and who has actually visited their various facilities.
The 8K verified that the CEO has put additional funds into Vystar to fuel its growth (1.2M) and that Vystar through Rotman’s has received 2.8M in PPP loans of which 1.4M has already been forgiven. Seems to me that prior posts concerned about Vystar’s survival are now a thing of the past. It will both survive and thrive.
Earlier this week Rotman’s released revenue information confirming a first quarter run rate of 15M in revenue making it possible that Vystar’s first quarter revenue will exceed the revenue in any prior 12 month period and blow away all prior quarters.
See tweet of an hour or so ago. Store revenue is over 9M from Jan 1 thru Feb 21. Current run rate of over 15M for Rotman’s alone with higher margins as only 1/2 the personnel cost compared to the first quarter of 2020 when Vystar’s revenue was less then 6M. We still do not know the contribution of Rx Air or online bedding sales in this first quarter but safe to assume these areas will contribute to the total revenue and still 37 days until end of this quarter
People continue to post predictions of bankruptcy for the store on this site. Those seem silly with hard data in hand.
Do you just make up your own facts. Vystar was essentially a bankrupt company in October of 2017. Mr Rotman became CEO in December of 2017 and with the store brought with him an infrastructure to allow Vystar to develop products and grow as a company. The acquisition of the furniture store was accomplished with Convertible Notes that did not dilute the shareholders as they have never been converted. He continues to support Vystar’s growth by loaning funds to the company at low interest.
Also, the new CDC Guidelines for the reopening of schools encourages schools to consider measure to deliver cleaner air to the environment and to decrease particle contaminants in the air. The Rx400 is able to do both in a classroom size environment and the Rx 3000 perfect for larger rooms. The new COVID 19 Bill contains $$ in it dedicated to the reopening of schools.
The next financial data will not be available until March 31 which will be the 10K. That will encompass the fourth quarter and the year. The first quarter 10Q will be due on May 15
Check out Twitter. $vyst
The 3,000 Rx 400 units were produced for and sold to a large distributor. Customized color and logo for a specific client
Containers already shipped
All shareholders of this stock should be aware of the Biden’s administration use of the Defense Procurement Act to produce and purchase 61M COVID 19 at home tests. Contracts will be awarded to six companies. Lucira appears to be poised to help increase testing in our country and around the world and make contact tracing a reality. The virus is not going away in the short term and influenza is always with us
As stated in recent 8K, Mr Rotman was not selling shares for personal gain but rather to use the proceeds to provide further funding to Vystar for both product development and product launch. This was to avoid shareholder dilution and debt instruments that could be detrimental to Vystar and its shareholders.
Think the Pfizer Vaccine which is still realistically months away created a huge buying opportunity for all COVID 19 stocks. What a gift!!!!!
Also believe COVID 19 is giving us a new normal just like 9/11. Still cannot walk freely in an airport today. Virus precautions and air purifiers will be part of this new normal
I am new to this Board but have been interested in Vystar for many years and first invested with its now deceased founder and the inventor of Vytex almost 30 years ago. Back then he invented materials that could be used in hospitals and could be dissolved saving the cost of pick up and burning. Back then shares sold privately for 50 cents and the company did an IPO at 25 dollars per share. These materials are still used today in the nuclear energy industry. Over ten years ago, I thought his concept of a non allergic latex was equally appealing.